EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

DEVELOPMENT AND OPTIMIZATION OF ESCULETIN LOADED FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES FOR TARGETED DELIVERY IN COLORECTAL CANCER

Gouri Devkar, Dr. Payal K. Thorat, Dr. Amol S. Rakte, Dr. Sanjay R. Arote

Genetics and Molecular Research · 07.07.2026

DOI: 10.4238/86yjtm66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 07.07.2026. Verfasst von Gouri Devkar und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To develop and optimize esculetin-loaded functionalized mesoporous silica nanoparticles (MSN-ESC-COOH) for targeted delivery in colorectal cancer using Box-Behnken factorial design, addressing esculetin's poor aqueous solubility and limited bioavailability.

Methods

Mesoporous silica nanoparticles (MSNs) were synthesized by a modified sol-gel method using CTAB, TEOS, and TEA. CTAB concentration (0.50–0.75 g), TEOS volume (7.5–10.0 mL) and TEA volume (1.5–2.5 mL) were optimalized using a three-factor, three-level Box-Behnken design to minimize the size of particles obtained and to maximize their entrapping efficiency. The optimized composition was characterized and the results are shown}. To extensively characterize the compounds, FTIR; differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD); field emission scanning electron microscopy (FESEM); dynamic light scattering (DLS); zeta potential determination; in vitro release kinetics and MTT cytotoxicity assay against HCT-116 colorectal cancer cells.

Results

A total of 17 formulations were optimized with a particle size and entrapment efficiency in the ranges of 102.4–214.3 nm and 53.4–82.4%, respectively. ANOVA indicated CTAB was the most significant factor (F = 325.38 for particle size; F = 264.25 for entrapment efficiency, p < 0.0001). Formulation DF9 was found optimal having particle size 102.4 ± 2.9 nm, PDI 0.188, zeta potential −30.2 ± 1.1 mV and entrapment efficiency (EE) as 82.4 ± 1.4% with desirability of 1,000 FTIR and PXRD confirm successful functionalization and drug amorphization. Release was controlled biphasic (72.4% at 12h) followed Korsmeyer-Peppas kinetics (n = 0.9038). MSN-ESC-COOH exhibited 1.81-fold improved cytotoxicity (IC50 = 21.38 μg/mL) compared to pure esculetin (IC50 = 38.64 μg/mL) at minimal carrier toxicity.

Conclusion

Here we demonstrate an optimized MSN-ESC-COOH nanoformulation as a potential targeted delivery platform for colorectal cancer therapy, with translational applicability meriting further in vivo evaluation of pharmacokinetics and efficacy.

Zitieren

APA

Devkar, G., Thorat, D. P. K., Rakte, D. A. S., & Arote, D. S. R. (2026). DEVELOPMENT AND OPTIMIZATION OF ESCULETIN LOADED FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES FOR TARGETED DELIVERY IN COLORECTAL CANCER. Genetics and Molecular Research. https://doi.org/10.4238/86yjtm66

Vancouver

Devkar G, Thorat DPK, Rakte DAS, Arote DSR. DEVELOPMENT AND OPTIMIZATION OF ESCULETIN LOADED FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES FOR TARGETED DELIVERY IN COLORECTAL CANCER. Genetics and Molecular Research. 2026. doi:10.4238/86yjtm66

BibTeX
@article{Devkar2026,
  author = {Devkar, Gouri and Thorat, Dr. Payal K. and Rakte, Dr. Amol S. and Arote, Dr. Sanjay R.},
  title = {DEVELOPMENT AND OPTIMIZATION OF ESCULETIN LOADED FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES FOR TARGETED DELIVERY IN COLORECTAL CANCER},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/86yjtm66}
}
Kostenlos starten →